UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
65 hedge funds and large institutions have $5.31M invested in Unity Biotechnology in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
7% less funds holding
Funds holding: 70 → 65 (-5)
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
63% less capital invested
Capital invested by funds: $14.2M → $5.31M (-$8.85M)
Holders
65
Holding in Top 10
1
Calls
$1.05M
Puts
$33K
Top Buyers
| 1 | +$88.3K | |
| 2 | +$48.9K | |
| 3 | +$36.3K | |
| 4 |
Renaissance Technologies
New York
|
+$28.8K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$26K |
Top Sellers
| 1 | -$686K | |
| 2 | -$681K | |
| 3 | -$238K | |
| 4 |
LPL Financial
San Diego,
California
|
-$84K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$81.3K |